BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32207885)

  • 1. Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.
    Lu D; Yang J; Liu X; Feng S; Dong X; Shi X; Zhai J; Mai S; Jiang J; Wang Z; Wu H; Cai K
    Cancer Med; 2020 May; 9(10):3455-3462. PubMed ID: 32207885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
    Kim M; Chung YS; Kim KA; Shim HS
    Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study.
    Li F; Zhao Y; Yuan L; Wang S; Mao Y
    J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
    Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
    Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
    J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
    Bertoglio P; Querzoli G; Ventura L; Aprile V; Cattoni MA; Nachira D; Lococo F; Rodriguez Perez M; Guerrera F; Minervini F; Gnetti L; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Viti A; Bogina GS; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Ampollini L; Terzi AC
    J Surg Oncol; 2021 Feb; 123(2):560-569. PubMed ID: 33169397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A propensity score matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma.
    Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Mar; 7(12):13880-5. PubMed ID: 26871600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary middle lobectomy for non-small-cell lung cancer: effectiveness and prognostic implications.
    Mazza F; Ferrari E; Maineri P; Venturino M; Dozin B; Ratto GB
    Eur J Cardiothorac Surg; 2015 Dec; 48(6):e117-23. PubMed ID: 26374866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resection.
    Wang Y; Wang R; Zheng D; Han B; Zhang J; Zhao H; Luo J; Zheng J; Chen T; Huang Q; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1043-1051. PubMed ID: 28204972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the long-term outcomes of segmentectomy and lobectomy for stage IA1 lung adenocarcinoma in patients with or without previous malignancy of other organs: a population-based study.
    Bai W; Zhang J; Wang Y; Zhou M; Liu L; Wang G; Zhao K; Gao X; Li S
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):215-228. PubMed ID: 34596477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm.
    Song W; Hou Y; Zhang J; Zhou Q
    Cancer Med; 2022 Dec; 11(24):4784-4795. PubMed ID: 35570370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authors' response: Comment on "clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma".
    Lu D; Yang J; Liu X; Feng S; Dong X; Shi X; Zhai J; Mai S; Jiang J; Wang Z; Wu H; Cai K
    Cancer Med; 2022 May; 11(9):2038-2039. PubMed ID: 35142110
    [No Abstract]   [Full Text] [Related]  

  • 18. Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.
    Tsao MS; Marguet S; Le Teuff G; Lantuejoul S; Shepherd FA; Seymour L; Kratzke R; Graziano SL; Popper HH; Rosell R; Douillard JY; Le-Chevalier T; Pignon JP; Soria JC; Brambilla EM
    J Clin Oncol; 2015 Oct; 33(30):3439-46. PubMed ID: 25918286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of tumor extension requiring bronchoplasty and pneumonectomy in patients with lung cancer and positive bronchoscopic findings.
    Sekine Y; Saitoh Y; Chiyo M; Yasufuku K; Iyoda A; Shibuya K; Iizasa T; Fujisawa T
    Surg Today; 2006; 36(6):491-8. PubMed ID: 16715416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.